NewAmsterdam Pharma Co N.V.
NAMS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 4 sales; 194 institutions reported holding it in 13F filings for Q2 2026, worth $4.13B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Other share classesNAMSW
Q2 2023 vs. Q1 2023
How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 19 | 29 | +10 |
| Shares | 33.3M | 48.8M | +15.5M (+46.4%) |
| Value | $444.9M | $580.6M | +$135.8M (+30.5%) |
New holders (11)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 1,200,000 | $14.3M | 0.03% |
| AXA S.A. | 224,351 | $2.67M | 0.01% |
| Alyeska Investment Group, L.P. | 129,547 | $1.54M | 0.01% |
| Affinity Asset Advisors, LLC | 100,000 | $1.19M | 0.47% |
| Monashee Investment Management LLC | 95,000 | $1.13M | 0.27% |
| Marshall Wace, LLP | 25,361 | $301.5K | 0.00% |
| Maven Securities LTD | 25,000 | $297.3K | 0.04% |
| Venture Visionary Partners LLC | 10,000 | $118.9K | 0.01% |
| Cutler Group LP | 500 | $5.00K | 0.00% |
| Wells Fargo & Company | 300 | $3.57K | 0.00% |
| UBS Group AG | 183 | $2.18K | 0.00% |
Sold out (1)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Wolverine Asset Management LLC | 4,819 | $63.9K |